Publication | Closed Access

Potential contribution of 131I-Labelled monoclonal anti-CEA antibodies in the treatment of liver metastases from colorectal carcinomas: Pretherapeutic study with dose recovery in resected tissues

Potential ContributionSurgical OncologyHepatologyMedicinePathologyColorectal CancerLiver MetastasesDose RecoveryLiver CancerOncologyRadiation OncologyTumor Microenvironment